AAIPHARMA ACQUIRES GERMAN CLINICAL DEVELOPMENT OPERATION

aaiPharma is acquiring a German-based clinical development team through its European subsidiary. Terms of the deal were not disclosed. aaiPharma (Pink sheets: AAIIQ) is acquiring a clinical research team of Rentschler Biotechnologie GmbH & Co. KG, a contract manufacturer of drugs containing recombinant proteins. AaiPharma said it would carry out a number of existing contracts with Rentschler on a subcontract basis. The firms will also work together on a "whole range of their technological and clinical expertise to customers of the pharmaceutical and biotechnology industries," aaiPharma said.

Local Tech Wire (http://www.localtechwire.com/article.cfm?u=12539)